Andersen Geir Øystein, Eritsland Jan, Aasheim Anders, Neuburger Jacob, Knudsen Eva Cecilie, Mangschau Arild
Hjerteovervåkningen, Hjertemedisinsk avdeling, Hjerte-lunge-senteret, Ullevål universitetssykehus, 0407 Oslo.
Tidsskr Nor Laegeforen. 2006 Sep 7;126(17):2264-7.
Diabetes and impaired glucose tolerance are associated with increased mortality in patients with acute myocardial infarction. We have used standardised oral glucose tolerance tests shortly after a myocardial infarction.
109 patients admitted with acute myocardial infarction were prospectively enrolled in the study. An oral glucose tolerance test was performed the first morning the patients were stable, without pain, nausea or hyperglycaemia. The patients were classified into normal glucose tolerance, impaired glucose tolerance or diabetes, according to the results of the oral glucose tolerance test and fasting plasma glucose levels.
109 patients (25 women) were included. Eight patients were previously diagnosed with diabetes type 2. Oral glucose tolerance was tested for 90 patients, usually the day after admission. The test was positive in 47 patients; 32 of them had 2-h plasma glucose levels between 7.8 and 11.0 mmol/L and were classified as having impaired glucose tolerance, and 15 had 2-h plasma glucose > or = 11.1 mmol/L and were classified as newly diagnosed diabetes patients. Similar body mass indexes and lipid values were found in patients with different glycometabolic states. Smoking was associated with a positive oral glucose tolerance test.
More than half of the patients with acute myocardial infarction had undiagnosed impaired glucose tolerance or diabetes type 2, as determined by an oral glucose tolerance test. The test could easily be performed shortly after a myocardial infarction in most of the patients. Oral glucose tolerance testing should be considered in all patients with coronary heart disease without a history of diagnosed diabetes.
糖尿病和糖耐量受损与急性心肌梗死患者死亡率增加相关。我们在心肌梗死后不久进行了标准化口服葡萄糖耐量试验。
109例急性心肌梗死患者前瞻性纳入本研究。在患者病情稳定、无疼痛、恶心或高血糖的第一个早晨进行口服葡萄糖耐量试验。根据口服葡萄糖耐量试验结果和空腹血糖水平,将患者分为糖耐量正常、糖耐量受损或糖尿病。
纳入109例患者(25例女性)。8例患者既往诊断为2型糖尿病。90例患者进行了口服葡萄糖耐量试验,通常在入院后第二天。47例患者试验呈阳性;其中32例2小时血糖水平在7.8至11.0 mmol/L之间,被分类为糖耐量受损,15例2小时血糖≥11.1 mmol/L,被分类为新诊断的糖尿病患者。不同糖代谢状态患者的体重指数和血脂值相似。吸烟与口服葡萄糖耐量试验阳性相关。
通过口服葡萄糖耐量试验确定,超过一半的急性心肌梗死患者存在未诊断的糖耐量受损或2型糖尿病。在大多数患者中,该试验可在心肌梗死后不久轻松进行。所有无糖尿病诊断史的冠心病患者均应考虑进行口服葡萄糖耐量试验。